Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 ILa | 0.00% | +7.41% | +11.54% |
12/05 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
09/05 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
Business Summary
Number of employees: 8
Sales per Business
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceuticals
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | +0.69% |
Sales per region
ILS in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | +0.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Motti Farbstein
CEO | Chief Executive Officer | 59 | 01/03/01 |
Pnina Fishman
FOU | Founder | 74 | 11/94/11 |
Ilan Cohn
FOU | Founder | 68 | 11/94/11 |
Zivit Harpaz
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Sari Fishman
PRN | Corporate Officer/Principal | 52 | 01/04/01 |
William D. Kerns
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Abraham Sartani
BRD | Director/Board Member | 76 | 01/01/01 |
Ilan Cohn
FOU | Founder | 68 | 11/94/11 |
Pnina Fishman
FOU | Founder | 74 | 11/94/11 |
Yaacov Goldman
BRD | Director/Board Member | 68 | 01/17/01 |
Guy Regev
BRD | Director/Board Member | 55 | 01/11/01 |
Yossi Bornstein
BRD | Director/Board Member | 66 | 05/21/05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,497,128,493 | 1,496,706,120 ( 99.97 %) | 0 | 99.97 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.54% | 1.18Cr | |
-2.35% | 8.97TCr | |
+2.50% | 4.13TCr | |
-12.01% | 3.37TCr | |
+62.74% | 2.61TCr | |
-19.79% | 1.46TCr | |
-8.58% | 1.28TCr | |
-12.34% | 1.17TCr | |
-43.92% | 1.15TCr | |
+4.27% | 892.43Cr |
- Stock Market
- Equities
- CANF Stock
- Company Can-Fite BioPharma Ltd.